Genteric, Inc.

Genteric, Inc. is a biotech company formed in 1997 to commercialize revolutionary gene delivery platforms and create new and improved protein drug therapies. Genteric's innovative systems enable a patient's gastrointestinal system to produce and secrete therapeutic proteins into the bloodstream. This novel approach holds much promise for becoming an effective cure for many important diseases. The Company's advanced technologies harness the body's natural protein production and distribution network. Using either viral or non-viral gene therapy techniques, Genteric's unique approach converts genes to therapeutic proteins within the patient's salivary glands and other gastrointestinal organs. This system then distributes the proteins to the bloodstream, achieving the desired therapeutic effect. This approach will permit the in vivo production and distribution of virtually any protein-based pharmaceutical.

Previous Forums
Date/Time		Forum
Jun 25 2001		BIO 2001 San Diego International Convention - Day 1 of 3

Market Assistant		PrecisionAlert
Earnings Data Annual Report		Enter your email address to receive alerts about this company